Press releases

Two papers on Embil's novel triple-active topical products (Neo-Penotran® Forte and Neo-Penotran® Forte-L) have been accepted for presentation at the 4'th World Conference on Vaginitis, Costa Rica, 10-13 Jan 2004 More

Postec (TM) is more efficacious than isolated topical steroid in the non surgical treatment of phimosis in children and adults More

Patent for technology which predicts early the ovulation of female mammals, including humans, using innovative measurements of sweat ion concentrations. More

Fertility Monitor Definitive Distribution Deal More

The Population Council, an international public health organisation and FemPharm Pty Ltd., a wholly-owned subsidiary of Acrux Limited, have signed a joint development agreement to test transdermal spray delivery of contraceptive formulations of Nesto More

Acrux Limited announced the commencement of Phase 2 clinical trials of its investigational product for treating women with low libido. More

OncoVEX GM-CSF is the first oncolytic virus (that selectively replicates in and kills tumour cells) containing an immune stimulating factor to enter clinical development. More

World renowned infertility clinicians and scientists gather to debate the newest research into the complexities of human eggs(oocytes) which form the basis of the human embryo More

Pheromone Sciences has successfully completed its field trial of its proprietary fertility and ovulation detection technology for large animal breeding More